Old Second National Bank of Aurora’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-900
Closed -$8K 372
2019
Q2
$8K Hold
900
﹤0.01% 324
2019
Q1
$14K Hold
900
0.01% 308
2018
Q4
$14K Hold
900
0.01% 299
2018
Q3
$19K Hold
900
0.01% 288
2018
Q2
$22K Buy
900
+150
+20% +$3.06K 0.01% 277
2018
Q1
$13K Hold
750
0.01% 288
2017
Q4
$14K Hold
750
0.01% 293
2017
Q3
$13K Hold
750
0.01% 304
2017
Q2
$25K Hold
750
0.01% 238
2017
Q1
$24K Hold
750
0.01% 239
2016
Q4
$27K Sell
750
-315
-30% -$12.6K 0.01% 223
2016
Q3
$49K Hold
1,065
0.02% 172
2016
Q2
$53K Sell
1,065
-20
-2% -$1.06K 0.02% 162
2016
Q1
$58K Hold
1,085
0.03% 162
2015
Q4
$71K Hold
1,085
0.03% 148
2015
Q3
$61K Sell
1,085
-36,016
-97% -$2.34M 0.03% 146
2015
Q2
$2.19M Buy
37,101
+1,125
+3% +$69.4K 1% 44
2015
Q1
$2.24M Buy
35,976
+2,209
+7% +$128K 0.99% 43
2014
Q4
$1.94M Buy
+33,767
New +$1.88M 0.85% 47

Other funds holding TEVA

Old Second National Bank of Aurora's TEVA Position: Q3 2019 in Review

Old Second National Bank of Aurora sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 900 shares — an estimated $8K sold.

Old Second National Bank of Aurora first reported a position in TEVA in Q4 2014 and held it in 19 quarters. The position peaked at $2.24M in Q1 2015. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Old Second National Bank of Aurora reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Old Second National Bank of Aurora sold 900 Teva Pharmaceuticals shares in Q3 2019, an estimated $8K.
  • Old Second National Bank of Aurora first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 19 quarters.
  • Old Second National Bank of Aurora's Teva Pharmaceuticals position peaked at $2.24M in Q1 2015.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Old Second National Bank of Aurora's 13F filing for Q3 2019, filed 25 Oct 2019.